ELEV Elevation Oncology Inc.

8.2
+0.1  (+1%)
Previous Close 8.1
Open 8.24
52 Week Low 7.71
52 Week High 16.22
Market Cap $187,142,286
Shares 22,822,230
Float 19,634,461
Enterprise Value $117,230,286
Volume 113,627
Av. Daily Volume 95,497
Stock charts supplied by TradingView

Upcoming Catalysts

Drug Stage Catalyst Date
Seribantumab (CRESTONE)
Solid Tumors
Phase 2
Phase 2
Premium membership is required to view catalyst dates, analyst ratings, earnings dates and cash burn data. Click here to unlock and sign up to a 14-day FREE TRIAL.